img

Global Cancer Drug Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cancer Drug Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.

The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.

Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
Cancer Drug Therapy report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cancer Drug Therapy market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Angiogenesis Inhibitors and mTOR Inhibitors are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cancer Drug Therapy industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cancer Drug Therapy key manufacturers include Amgen / Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Merck and Roche, etc. Amgen / Allergan, Argos Therapeutics, AstraZeneca are top 3 players and held % sales share in total in 2022.
Cancer Drug Therapy can be divided into Targeted Therapy, Chemotherapy and Immunotherapy,, etc. Targeted Therapy is the mainstream product in the market, accounting for % sales share globally in 2022.
Cancer Drug Therapy is widely used in various fields, such as Angiogenesis Inhibitors, mTOR Inhibitors, Monoclonal Antibodies and Cytokine Immunotherapy (IL-2), etc. Angiogenesis Inhibitors provides greatest supports to the Cancer Drug Therapy industry development. In 2022, global % sales of Cancer Drug Therapy went into Angiogenesis Inhibitors filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cancer Drug Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
Segment by Type
Targeted Therapy
Chemotherapy
Immunotherapy

Segment by Application


Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cancer Drug Therapy market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cancer Drug Therapy, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cancer Drug Therapy industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cancer Drug Therapy in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cancer Drug Therapy introduction, etc. Cancer Drug Therapy Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Cancer Drug Therapy market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Cancer Drug Therapy Market Overview
1.1 Cancer Drug Therapy Product Overview
1.2 Cancer Drug Therapy Market Segment by Type
1.2.1 Targeted Therapy
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.3 Global Cancer Drug Therapy Market Size by Type
1.3.1 Global Cancer Drug Therapy Market Size Overview by Type (2018-2034)
1.3.2 Global Cancer Drug Therapy Historic Market Size Review by Type (2018-2024)
1.3.3 Global Cancer Drug Therapy Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cancer Drug Therapy Sales Breakdown by Type (2018-2024)
1.4.2 Europe Cancer Drug Therapy Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Cancer Drug Therapy Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Cancer Drug Therapy Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Cancer Drug Therapy Sales Breakdown by Type (2018-2024)
2 Global Cancer Drug Therapy Market Competition by Company
2.1 Global Top Players by Cancer Drug Therapy Sales (2018-2024)
2.2 Global Top Players by Cancer Drug Therapy Revenue (2018-2024)
2.3 Global Top Players by Cancer Drug Therapy Price (2018-2024)
2.4 Global Top Manufacturers Cancer Drug Therapy Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cancer Drug Therapy Market Competitive Situation and Trends
2.5.1 Cancer Drug Therapy Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Cancer Drug Therapy Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Drug Therapy as of 2022)
2.7 Date of Key Manufacturers Enter into Cancer Drug Therapy Market
2.8 Key Manufacturers Cancer Drug Therapy Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cancer Drug Therapy Status and Outlook by Region
3.1 Global Cancer Drug Therapy Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Cancer Drug Therapy Historic Market Size by Region
3.2.1 Global Cancer Drug Therapy Sales in Volume by Region (2018-2024)
3.2.2 Global Cancer Drug Therapy Sales in Value by Region (2018-2024)
3.2.3 Global Cancer Drug Therapy Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Cancer Drug Therapy Forecasted Market Size by Region
3.3.1 Global Cancer Drug Therapy Sales in Volume by Region (2024-2034)
3.3.2 Global Cancer Drug Therapy Sales in Value by Region (2024-2034)
3.3.3 Global Cancer Drug Therapy Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Cancer Drug Therapy by Application
4.1 Cancer Drug Therapy Market Segment by Application
4.1.1 Angiogenesis Inhibitors
4.1.2 mTOR Inhibitors
4.1.3 Monoclonal Antibodies
4.1.4 Cytokine Immunotherapy (IL-2)
4.2 Global Cancer Drug Therapy Market Size by Application
4.2.1 Global Cancer Drug Therapy Market Size Overview by Application (2018-2034)
4.2.2 Global Cancer Drug Therapy Historic Market Size Review by Application (2018-2024)
4.2.3 Global Cancer Drug Therapy Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cancer Drug Therapy Sales Breakdown by Application (2018-2024)
4.3.2 Europe Cancer Drug Therapy Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Cancer Drug Therapy Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Cancer Drug Therapy Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Cancer Drug Therapy Sales Breakdown by Application (2018-2024)
5 North America Cancer Drug Therapy by Country
5.1 North America Cancer Drug Therapy Historic Market Size by Country
5.1.1 North America Cancer Drug Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Cancer Drug Therapy Sales in Volume by Country (2018-2024)
5.1.3 North America Cancer Drug Therapy Sales in Value by Country (2018-2024)
5.2 North America Cancer Drug Therapy Forecasted Market Size by Country
5.2.1 North America Cancer Drug Therapy Sales in Volume by Country (2024-2034)
5.2.2 North America Cancer Drug Therapy Sales in Value by Country (2024-2034)
6 Europe Cancer Drug Therapy by Country
6.1 Europe Cancer Drug Therapy Historic Market Size by Country
6.1.1 Europe Cancer Drug Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Cancer Drug Therapy Sales in Volume by Country (2018-2024)
6.1.3 Europe Cancer Drug Therapy Sales in Value by Country (2018-2024)
6.2 Europe Cancer Drug Therapy Forecasted Market Size by Country
6.2.1 Europe Cancer Drug Therapy Sales in Volume by Country (2024-2034)
6.2.2 Europe Cancer Drug Therapy Sales in Value by Country (2024-2034)
7 Asia-Pacific Cancer Drug Therapy by Region
7.1 Asia-Pacific Cancer Drug Therapy Historic Market Size by Region
7.1.1 Asia-Pacific Cancer Drug Therapy Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Cancer Drug Therapy Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Cancer Drug Therapy Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Cancer Drug Therapy Forecasted Market Size by Region
7.2.1 Asia-Pacific Cancer Drug Therapy Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Cancer Drug Therapy Sales in Value by Region (2024-2034)
8 Latin America Cancer Drug Therapy by Country
8.1 Latin America Cancer Drug Therapy Historic Market Size by Country
8.1.1 Latin America Cancer Drug Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Cancer Drug Therapy Sales in Volume by Country (2018-2024)
8.1.3 Latin America Cancer Drug Therapy Sales in Value by Country (2018-2024)
8.2 Latin America Cancer Drug Therapy Forecasted Market Size by Country
8.2.1 Latin America Cancer Drug Therapy Sales in Volume by Country (2024-2034)
8.2.2 Latin America Cancer Drug Therapy Sales in Value by Country (2024-2034)
9 Middle East and Africa Cancer Drug Therapy by Country
9.1 Middle East and Africa Cancer Drug Therapy Historic Market Size by Country
9.1.1 Middle East and Africa Cancer Drug Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Cancer Drug Therapy Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Cancer Drug Therapy Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Cancer Drug Therapy Forecasted Market Size by Country
9.2.1 Middle East and Africa Cancer Drug Therapy Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Cancer Drug Therapy Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Amgen / Allergan
10.1.1 Amgen / Allergan Company Information
10.1.2 Amgen / Allergan Introduction and Business Overview
10.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Amgen / Allergan Cancer Drug Therapy Products Offered
10.1.5 Amgen / Allergan Recent Development
10.2 Argos Therapeutics
10.2.1 Argos Therapeutics Company Information
10.2.2 Argos Therapeutics Introduction and Business Overview
10.2.3 Argos Therapeutics Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Argos Therapeutics Cancer Drug Therapy Products Offered
10.2.5 Argos Therapeutics Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.3.4 AstraZeneca Cancer Drug Therapy Products Offered
10.3.5 AstraZeneca Recent Development
10.4 Aveo Pharmaceuticals
10.4.1 Aveo Pharmaceuticals Company Information
10.4.2 Aveo Pharmaceuticals Introduction and Business Overview
10.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Products Offered
10.4.5 Aveo Pharmaceuticals Recent Development
10.5 Bayer
10.5.1 Bayer Company Information
10.5.2 Bayer Introduction and Business Overview
10.5.3 Bayer Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bayer Cancer Drug Therapy Products Offered
10.5.5 Bayer Recent Development
10.6 Exelixis
10.6.1 Exelixis Company Information
10.6.2 Exelixis Introduction and Business Overview
10.6.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Exelixis Cancer Drug Therapy Products Offered
10.6.5 Exelixis Recent Development
10.7 Incyte
10.7.1 Incyte Company Information
10.7.2 Incyte Introduction and Business Overview
10.7.3 Incyte Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Incyte Cancer Drug Therapy Products Offered
10.7.5 Incyte Recent Development
10.8 Merck
10.8.1 Merck Company Information
10.8.2 Merck Introduction and Business Overview
10.8.3 Merck Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Merck Cancer Drug Therapy Products Offered
10.8.5 Merck Recent Development
10.9 Roche
10.9.1 Roche Company Information
10.9.2 Roche Introduction and Business Overview
10.9.3 Roche Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Roche Cancer Drug Therapy Products Offered
10.9.5 Roche Recent Development
10.10 Bristol-Myers Squibb
10.10.1 Bristol-Myers Squibb Company Information
10.10.2 Bristol-Myers Squibb Introduction and Business Overview
10.10.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bristol-Myers Squibb Cancer Drug Therapy Products Offered
10.10.5 Bristol-Myers Squibb Recent Development
10.11 Eisai
10.11.1 Eisai Company Information
10.11.2 Eisai Introduction and Business Overview
10.11.3 Eisai Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Eisai Cancer Drug Therapy Products Offered
10.11.5 Eisai Recent Development
10.12 Exelixis
10.12.1 Exelixis Company Information
10.12.2 Exelixis Introduction and Business Overview
10.12.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Exelixis Cancer Drug Therapy Products Offered
10.12.5 Exelixis Recent Development
10.13 Genentech (Roche)
10.13.1 Genentech (Roche) Company Information
10.13.2 Genentech (Roche) Introduction and Business Overview
10.13.3 Genentech (Roche) Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Genentech (Roche) Cancer Drug Therapy Products Offered
10.13.5 Genentech (Roche) Recent Development
10.14 Novartis
10.14.1 Novartis Company Information
10.14.2 Novartis Introduction and Business Overview
10.14.3 Novartis Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Novartis Cancer Drug Therapy Products Offered
10.14.5 Novartis Recent Development
10.15 Pfizer
10.15.1 Pfizer Company Information
10.15.2 Pfizer Introduction and Business Overview
10.15.3 Pfizer Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Pfizer Cancer Drug Therapy Products Offered
10.15.5 Pfizer Recent Development
10.16 Prometheus Labs
10.16.1 Prometheus Labs Company Information
10.16.2 Prometheus Labs Introduction and Business Overview
10.16.3 Prometheus Labs Cancer Drug Therapy Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Prometheus Labs Cancer Drug Therapy Products Offered
10.16.5 Prometheus Labs Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cancer Drug Therapy Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cancer Drug Therapy Industrial Chain Analysis
11.4 Cancer Drug Therapy Market Dynamics
11.4.1 Cancer Drug Therapy Industry Trends
11.4.2 Cancer Drug Therapy Market Drivers
11.4.3 Cancer Drug Therapy Market Challenges
11.4.4 Cancer Drug Therapy Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cancer Drug Therapy Distributors
12.3 Cancer Drug Therapy Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Targeted Therapy
Table 2. Major Company of Chemotherapy
Table 3. Major Company of Immunotherapy
Table 4. Global Cancer Drug Therapy Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Cancer Drug Therapy Sales by Type (2018-2024) & (K Units)
Table 6. Global Cancer Drug Therapy Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Cancer Drug Therapy Sales by Type (2018-2024) & (US& Million)
Table 8. Global Cancer Drug Therapy Market Share in Value by Type (2018-2024)
Table 9. Global Cancer Drug Therapy Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Cancer Drug Therapy Sales by Type (2024-2034) & (K Units)
Table 11. Global Cancer Drug Therapy Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Cancer Drug Therapy Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Cancer Drug Therapy Sales Market Share in Value by Type (2024-2034)
Table 14. Global Cancer Drug Therapy Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Cancer Drug Therapy Sales by Type (2018-2024) & (K Units)
Table 16. North America Cancer Drug Therapy Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Cancer Drug Therapy Sales (K Units) by Type (2018-2024)
Table 18. Europe Cancer Drug Therapy Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Cancer Drug Therapy Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Cancer Drug Therapy Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Cancer Drug Therapy Sales (K Units) by Type (2018-2024)
Table 22. Latin America Cancer Drug Therapy Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Cancer Drug Therapy Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Cancer Drug Therapy Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Cancer Drug Therapy Sales by Company (2018-2024) & (K Units)
Table 26. Global Cancer Drug Therapy Sales Share by Company (2018-2024)
Table 27. Global Cancer Drug Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Cancer Drug Therapy Revenue Share by Company (2018-2024)
Table 29. Global Market Cancer Drug Therapy Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Cancer Drug Therapy Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Cancer Drug Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Drug Therapy as of 2022)
Table 33. Date of Key Manufacturers Enter into Cancer Drug Therapy Market
Table 34. Key Manufacturers Cancer Drug Therapy Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Cancer Drug Therapy Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Cancer Drug Therapy Sales by Region (2018-2024) & (K Units)
Table 38. Global Cancer Drug Therapy Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Cancer Drug Therapy Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Cancer Drug Therapy Sales Market Share in Value by Region (2018-2024)
Table 41. Global Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Cancer Drug Therapy Sales by Region (2024-2034) & (K Units)
Table 43. Global Cancer Drug Therapy Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Cancer Drug Therapy Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Cancer Drug Therapy Sales Market Share in Value by Region (2024-2034)
Table 46. Global Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Cancer Drug Therapy Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Cancer Drug Therapy Sales by Application (2018-2024) & (K Units)
Table 49. Global Cancer Drug Therapy Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Cancer Drug Therapy Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Cancer Drug Therapy Sales Market Share in Value by Application (2018-2024)
Table 52. Global Cancer Drug Therapy Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Cancer Drug Therapy Sales by Application (2024-2034) & (K Units)
Table 54. Global Cancer Drug Therapy Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Cancer Drug Therapy Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Cancer Drug Therapy Sales Market Share in Value by Application (2024-2034)
Table 57. Global Cancer Drug Therapy Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Cancer Drug Therapy Sales by Application (2018-2024) (K Units)
Table 59. North America Cancer Drug Therapy Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Cancer Drug Therapy Sales by Application (2018-2024) (K Units)
Table 61. Europe Cancer Drug Therapy Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Cancer Drug Therapy Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Cancer Drug Therapy Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Cancer Drug Therapy Sales by Application (2018-2024) (K Units)
Table 65. Latin America Cancer Drug Therapy Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Cancer Drug Therapy Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Cancer Drug Therapy Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Cancer Drug Therapy Sales by Country (2018-2024) & (K Units)
Table 69. North America Cancer Drug Therapy Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Cancer Drug Therapy Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Cancer Drug Therapy Sales Market Share in Value by Country (2018-2024)
Table 72. North America Cancer Drug Therapy Sales by Country (2024-2034) & (K Units)
Table 73. North America Cancer Drug Therapy Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Cancer Drug Therapy Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Cancer Drug Therapy Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Cancer Drug Therapy Sales by Country (2018-2024) & (K Units)
Table 77. Europe Cancer Drug Therapy Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Cancer Drug Therapy Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Cancer Drug Therapy Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Cancer Drug Therapy Sales by Country (2024-2034) & (K Units)
Table 81. Europe Cancer Drug Therapy Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Cancer Drug Therapy Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Cancer Drug Therapy Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Cancer Drug Therapy Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Cancer Drug Therapy Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Cancer Drug Therapy Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Cancer Drug Therapy Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Cancer Drug Therapy Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Cancer Drug Therapy Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Cancer Drug Therapy Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Cancer Drug Therapy Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Cancer Drug Therapy Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Cancer Drug Therapy Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Cancer Drug Therapy Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Cancer Drug Therapy Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Cancer Drug Therapy Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Cancer Drug Therapy Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Cancer Drug Therapy Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Cancer Drug Therapy Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Cancer Drug Therapy Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Cancer Drug Therapy Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Cancer Drug Therapy Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Cancer Drug Therapy Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Cancer Drug Therapy Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Cancer Drug Therapy Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Cancer Drug Therapy Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Cancer Drug Therapy Sales Market Share in Value by Country (2024-2034)
Table 108. Amgen / Allergan Company Information
Table 109. Amgen / Allergan Introduction and Business Overview
Table 110. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Amgen / Allergan Cancer Drug Therapy Product
Table 112. Amgen / Allergan Recent Development
Table 113. Argos Therapeutics Company Information
Table 114. Argos Therapeutics Introduction and Business Overview
Table 115. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Argos Therapeutics Cancer Drug Therapy Product
Table 117. Argos Therapeutics Recent Development
Table 118. AstraZeneca Company Information
Table 119. AstraZeneca Introduction and Business Overview
Table 120. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. AstraZeneca Cancer Drug Therapy Product
Table 122. AstraZeneca Recent Development
Table 123. Aveo Pharmaceuticals Company Information
Table 124. Aveo Pharmaceuticals Introduction and Business Overview
Table 125. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Aveo Pharmaceuticals Cancer Drug Therapy Product
Table 127. Aveo Pharmaceuticals Recent Development
Table 128. Bayer Company Information
Table 129. Bayer Introduction and Business Overview
Table 130. Bayer Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Bayer Cancer Drug Therapy Product
Table 132. Bayer Recent Development
Table 133. Exelixis Company Information
Table 134. Exelixis Introduction and Business Overview
Table 135. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Exelixis Cancer Drug Therapy Product
Table 137. Exelixis Recent Development
Table 138. Incyte Company Information
Table 139. Incyte Introduction and Business Overview
Table 140. Incyte Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Incyte Cancer Drug Therapy Product
Table 142. Incyte Recent Development
Table 143. Merck Company Information
Table 144. Merck Introduction and Business Overview
Table 145. Merck Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Merck Cancer Drug Therapy Product
Table 147. Merck Recent Development
Table 148. Roche Company Information
Table 149. Roche Introduction and Business Overview
Table 150. Roche Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Roche Cancer Drug Therapy Product
Table 152. Roche Recent Development
Table 153. Bristol-Myers Squibb Company Information
Table 154. Bristol-Myers Squibb Introduction and Business Overview
Table 155. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Bristol-Myers Squibb Cancer Drug Therapy Product
Table 157. Bristol-Myers Squibb Recent Development
Table 158. Eisai Company Information
Table 159. Eisai Introduction and Business Overview
Table 160. Eisai Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Eisai Cancer Drug Therapy Product
Table 162. Eisai Recent Development
Table 163. Exelixis Company Information
Table 164. Exelixis Introduction and Business Overview
Table 165. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Exelixis Cancer Drug Therapy Product
Table 167. Exelixis Recent Development
Table 168. Genentech (Roche) Company Information
Table 169. Genentech (Roche) Introduction and Business Overview
Table 170. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Genentech (Roche) Cancer Drug Therapy Product
Table 172. Genentech (Roche) Recent Development
Table 173. Novartis Company Information
Table 174. Novartis Introduction and Business Overview
Table 175. Novartis Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Novartis Cancer Drug Therapy Product
Table 177. Novartis Recent Development
Table 178. Pfizer Company Information
Table 179. Pfizer Introduction and Business Overview
Table 180. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Pfizer Cancer Drug Therapy Product
Table 182. Pfizer Recent Development
Table 183. Prometheus Labs Company Information
Table 184. Prometheus Labs Introduction and Business Overview
Table 185. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Prometheus Labs Cancer Drug Therapy Product
Table 187. Prometheus Labs Recent Development
Table 188. Key Raw Materials Lists
Table 189. Raw Materials Key Suppliers Lists
Table 190. Cancer Drug Therapy Market Trends
Table 191. Cancer Drug Therapy Market Drivers
Table 192. Cancer Drug Therapy Market Challenges
Table 193. Cancer Drug Therapy Market Restraints
Table 194. Cancer Drug Therapy Distributors List
Table 195. Cancer Drug Therapy Downstream Customers
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Drug Therapy Product Picture
Figure 2. Global Cancer Drug Therapy Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Cancer Drug Therapy Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Cancer Drug Therapy Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Targeted Therapy
Figure 6. Global Targeted Therapy Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Chemotherapy
Figure 8. Global Chemotherapy Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Immunotherapy
Figure 10. Global Immunotherapy Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Cancer Drug Therapy Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Cancer Drug Therapy Sales Market Share by Type in 2022 & 2034
Figure 13. North America Cancer Drug Therapy Sales Market Share in Volume by Type in 2022
Figure 14. North America Cancer Drug Therapy Sales Market Share in Value by Type in 2022
Figure 15. Europe Cancer Drug Therapy Sales Market Share in Volume by Type in 2022
Figure 16. Europe Cancer Drug Therapy Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Cancer Drug Therapy Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Cancer Drug Therapy Sales Market Share in Value by Type in 2022
Figure 19. Latin America Cancer Drug Therapy Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Cancer Drug Therapy Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Cancer Drug Therapy Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Cancer Drug Therapy Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Drug Therapy Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Drug Therapy Revenue in 2022
Figure 25. Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Angiogenesis Inhibitors
Figure 27. Global Angiogenesis Inhibitors Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of mTOR Inhibitors
Figure 29. Global mTOR Inhibitors Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Monoclonal Antibodies
Figure 31. Global Monoclonal Antibodies Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Cytokine Immunotherapy (IL-2)
Figure 33. Global Cytokine Immunotherapy (IL-2) Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Cancer Drug Therapy Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Cancer Drug Therapy Sales Market Share by Application in 2022 & 2034
Figure 36. North America Cancer Drug Therapy Sales Market Share in Volume by Application in 2022
Figure 37. North America Cancer Drug Therapy Sales Market Share in Value by Application in 2022
Figure 38. Europe Cancer Drug Therapy Sales Market Share in Volume by Application in 2022
Figure 39. Europe Cancer Drug Therapy Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Cancer Drug Therapy Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Cancer Drug Therapy Sales Market Share in Value by Application in 2022
Figure 42. Latin America Cancer Drug Therapy Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Cancer Drug Therapy Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Cancer Drug Therapy Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Cancer Drug Therapy Manufacturing Cost Structure
Figure 47. Cancer Drug Therapy Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries